Mawer Investment Management Ltd. Has $18.63 Million Stake in Express Scripts Holding (ESRX)

Mawer Investment Management Ltd. reduced its position in Express Scripts Holding (NASDAQ:ESRX) by 30.4% during the 4th quarter, HoldingsChannel reports. The fund owned 249,566 shares of the company’s stock after selling 109,071 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Express Scripts were worth $18,628,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Van ECK Associates Corp boosted its holdings in shares of Express Scripts by 5.1% during the third quarter. Van ECK Associates Corp now owns 506,511 shares of the company’s stock worth $32,072,000 after purchasing an additional 24,728 shares during the period. Victory Capital Management Inc. boosted its holdings in shares of Express Scripts by 12.5% during the third quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock worth $2,243,000 after purchasing an additional 3,940 shares during the period. Hendershot Investments Inc. acquired a new stake in shares of Express Scripts during the third quarter worth approximately $5,132,000. Crossmark Global Holdings Inc. acquired a new stake in shares of Express Scripts during the third quarter worth approximately $3,708,000. Finally, LMR Partners LLP acquired a new stake in shares of Express Scripts during the third quarter worth approximately $3,230,000. Institutional investors and hedge funds own 86.45% of the company’s stock.

Shares of Express Scripts Holding (ESRX) opened at $76.05 on Wednesday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. The stock has a market cap of $42,608.24, a P/E ratio of 11.00, a price-to-earnings-growth ratio of 0.81 and a beta of 0.93. Express Scripts Holding has a one year low of $55.80 and a one year high of $83.49.

Express Scripts announced that its Board of Directors has authorized a share buyback program on Monday, December 18th that permits the company to repurchase 45,000,000 shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s management believes its shares are undervalued.

In other Express Scripts news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Glen D. Stettin sold 3,449 shares of Express Scripts stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total transaction of $279,369.00. Following the completion of the sale, the vice president now owns 33,715 shares of the company’s stock, valued at $2,730,915. The disclosure for this sale can be found here. Insiders sold 17,001 shares of company stock valued at $1,249,505 over the last quarter. Corporate insiders own 0.68% of the company’s stock.

Several analysts recently commented on the stock. BidaskClub cut shares of Express Scripts from a “buy” rating to a “hold” rating in a report on Wednesday, February 14th. SunTrust Banks set a $82.00 price target on shares of Express Scripts and gave the stock a “buy” rating in a report on Thursday, December 14th. Jefferies Group restated a “buy” rating on shares of Express Scripts in a report on Thursday, October 26th. Royal Bank of Canada set a $68.00 price target on shares of Express Scripts and gave the stock a “hold” rating in a report on Friday, December 15th. Finally, Zacks Investment Research cut shares of Express Scripts from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Five equities research analysts have rated the stock with a sell rating, eight have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Express Scripts currently has an average rating of “Hold” and an average price target of $78.93.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/02/21/mawer-investment-management-ltd-has-18-63-million-stake-in-express-scripts-holding-esrx.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply